Search Results
DKD treatment update: SGLT2 inhibitors and finerenone | Ian de Boer & Amrit Lamba
Dr George Bakris Compares FIDELIO-DKD Renal Outcomes With Those of SGLT-2 Inhibitor Trials
Dr Rajiv Agarwal Discusses Finerenone, Results of FIDELIO-DKD
George Bakris, MD | Use of Finerenone in Patients with Diabetes Who Have Kidney Disease
FIGARO: Where will finerenone fit into diabetic kidney disease treatment | David Wheeler
Medical Grand Rounds, October 14, 2021
FIGARO-DKD Trial Results
Dr Su Ern Yeoh - SGLT2 Inhibitors in Heart Failure and Diuretic Resistance
Jennifer Green, EASD 2022: Finerenone & Empagliflozin in patients with CKD and T2D: CONFIDENCE Study
Dr Julie Lovshin - SGLT2i Cardiorenal mechanisms in diabetes and beyond - full presentation
Can we use SGLT2 Inhibitor in diabetic patient with recurrent urinary tract infections?
Effects of canagliflozin versus finerenone on cardiorenal outcomes
